AtriCure (ATRC) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Piper Jaffray Reiterates Outperform as AtriCure (ATRC) Reports Strong 4Q Results
February 24, 2016 10:10 AM ESTPiper Jaffray maintained an Overweight rating on AtriCure Inc. (NASDAQ: ATRC), and cut the price target to $22.00 (from $25.00), following the company's 4Q earnings report. ATRC reported revenues that came in-line with it's Januarys pre-announcement. The loss per share was a little less than expected, due to lower-than-expected R&D expenses.
Analyst... More
